• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Ophthalmol . Effect of the Coronavirus Disease 2019 Pandemic on Retinal Artery Occlusion

tetano

Editor, Senior Moderator
J Ophthalmol


. 2026 May 5:2026:5740618.
doi: 10.1155/joph/5740618. eCollection 2026.
Effect of the Coronavirus Disease 2019 Pandemic on Retinal Artery Occlusion

Tetsuya Muto[SUP] 1 2 3 [/SUP], Shigeki Machida[SUP] 2 [/SUP], Shinichiro Imaizumi[SUP] 1 [/SUP], Tetsuju Sekiryu[SUP] 3 [/SUP]


Affiliations
Abstract

Purpose: To determine the prevalence and clinical characteristics of retinal artery occlusion (RAO), including branch RAO (BRAO) and central RAO (CRAO), among new patients before and after the declaration of a state of emergency due to coronavirus disease 2019 (April 7, 2020) in Japan.
Methods: New patients and patients with newly diagnosed RAO were categorized into "Before" and "After" groups based on the initial visit. The prevalence, sex ratio, and age of patients newly diagnosed with RAO were compared between the groups. The rates of patients newly diagnosed with rhegmatogenous retinal detachment (RRD) and pseudoexfoliation glaucoma (PEX) were also examined in the Before and After groups.
Results: This study included 53 and 31 patients with BRAO and 55 and 40 patients with CRAO in the Before and After groups, respectively. There were no significant differences in prevalence of RAOs among newly diagnosed patients (BRAO: p = 0.449; CRAO: p = 0.060), patients with RRD (BRAO: p = 0.425; CRAO: p = 0.082), or patients with PEX (BRAO: p = 0.317; CRAO: p = 0.072), as well as in sex ratio and age. Although initial best-corrected visual acuity (BRAO: p = 0.303; CRAO: p = 0.291) of RAOs showed no significant differences, the final best-corrected visual acuity in BRAO significantly worsened in the After group (p = 0.002).
Conclusions: Although the coronavirus disease 2019 pandemic did not affect the prevalence of RAOs among new patients compared with that of RRD and PEX, it may have affected its pathophysiology.

Keywords: best-corrected visual acuity; branch retinal artery occlusion; central retinal artery occlusion; coronavirus disease 2019; prevalence.

 
Back
Top